Mon, Oct 20, 2014, 9:14 AM EDT - U.S. Markets open in 16 mins.


% | $
Quotes you view appear here for quick access.

Nektar Therapeutics (NKTR) Message Board

  • corona_and_a_cigar corona_and_a_cigar Nov 15, 2012 3:17 PM Flag

    NKTR-119 - from the transcript

    HR seems to be indicating that AZN has great interest in 119

    Bert Hazlett - ROTH Capital Partners
    Thank you. Thank you for taking the question. Just my line has been in and out, my apologies for this. But you just answered the discontinuation rate question, but could you just comment on how this impacts the follow-on combinations? Do you know anything with those programs at this point or you need the additional trial data to make that determination? Thanks.

    Howard W. Robin - President and Chief Executive Officer
    I think, if you’re asking me, whether AZ wants to move forward with NKTR-119. I mean I can’t comment on that. I think they have every interest in moving this program forward and my guess is that as this program moves forward, they will probably be very pleased to move NKRT-119 forward. But that – but that isn’t something we are ready to share with anyone yet.

    Bert Hazlett - ROTH Capital Partners
    Okay. And do you think that that’s a decision that will be made at the time of the decision of filing for 118?

    Howard W. Robin - President and Chief Executive Officer
    I think it could come before that. I mean, honestly I don’t have any specific timing as to when they might announce that they want to move NKTR-119 forward. I’m sure they are actively evaluating that.

    Bert Hazlett - ROTH Capital Partners
    Okay. Thank you very much.

12.40Oct 17 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
NewLink Genetics Corporation
NasdaqGMFri, Oct 17, 2014 4:00 PM EDT